GauravDharMD

Interventional Cardiology

Section Chief Structural Heart Disease, Rush University Medical Center Program Director Structural Heart Disease, Professor of Medicine/Cardiology, Rush College of Medicine

Request Appointment

Overview of Dr. Dhar

Dr. Gaurav Dhar is an International cardiologist in Little Rock, AR and is the Director of Interventional Cardiology at UAMS. He received his medical degree from Government Medical College of Jammu and Kashmir and has been in practice 21 years. He specializes in Structural and interventional cardiology and is experienced in general cardiology, coronary artery disease, valvular heart disease, interventional cardiology, and cardiac catheterization.

Office
1717 W. Congress Pkwy, Kellogg Suite307
Chicago, IL 60612
Book by Phone+1(872) 285-8256

Education & Training

University of ChicagoFellowship, Interventional Cardiology, 2008 - 2009
Advocate Health Care/Advocate Illinois Masonic Medical CenterFellowship, Cardiovascular Disease, 2002 - 2005
Louis A Weiss Memorial HospitalChief Residency, Internal Medicine, 2001 - 2002
Louis A Weiss Memorial HospitalResidency, Internal Medicine, 1998 - 2001
Government Medical College of Jammu and KashmireClass of 1996

Certifications & Licensure

IL State Medical License 1998 - 2026
IN State Medical License 2024 - 2025
AR State Medical License 2020 - 2024
MI State Medical License 2005 - 2024
PA State Medical License 2005 - 2006
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

FSCAI Society for Coronary Angiography and Intervention
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACC) American College of Cardiology

Clinical Trials

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Start of enrollment: 2014 May 01
Recruiting
Not Applicable
A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart Start of enrollment: 2015 Jun 04
Completed
Phase 4
AMPLATZER™ Amulet™ LAA Occluder Trial Start of enrollment: 2016 Aug 24
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

2 citations
Transcatheter interventions for severe tricuspid regurgitation: a literature review.
Pramod Kumar Ponna, Stephen Patin, Naga Sai Shravan Turaga, Dominika M Zoltowska, Vishal Devarkonda
Journal of Geriatric Cardiology. 2022-07-28
6 citations
Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART.
Munthir Mansour, Qais Radaideh, Malek N. Alaiwah, Yanal Alnimer, Subodh R. Devabhaktuni
The International Journal of Cardiovascular Imaging. 2021-10-10
2 citations
Percutaneous Aspiration (AngioVac) of a Mitral Valve Vegetation followed by a Transcatheter Mitral Valve-in-Valve Intervention.
Jack Xu, Shravan Turaga, Jay Bhama, Srikanth Vallurupalli, Gaurav Dhar
Methodist Debakey Cardiovascular Journal. 2022-01-01

Journal Articles

Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients with End-Stage Renal Disease
Mandeep S Randhawa, Gaurav Dhar, JAMA Network Open